<?xml version="1.0" encoding="UTF-8"?>
<p>A group of 12 EO at three different doses (
 <xref rid="animals-11-01205-t001" ref-type="table">Table 1</xref>) were selected based on previous studies [
 <xref rid="B18-animals-11-01205" ref-type="bibr">18</xref>,
 <xref rid="B19-animals-11-01205" ref-type="bibr">19</xref>,
 <xref rid="B20-animals-11-01205" ref-type="bibr">20</xref>], the Rumen Up project (
 <uri xlink:href="https://www.abdn.ac.uk/research/rumen-up/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.abdn.ac.uk/research/rumen-up/</uri> accessed on 18 September 2018), commercial availability, reasonable price and legal status in the EU. All EO were supplied by TECHNA France Nutrition (CouÃ«ron, France).
</p>
